Background: Infections are a common and serious threat to patients with acute ischemic stroke. The aim of this study was to assess the effect of infection on mortality and functional outcome at discharge and at 1 year. Methods: From a consecutive cohort study in 11 centers, the Netherlands Stroke Survey, we selected 521 patients with ischemic stroke admitted to hospital within 48 h of onset. Stroke-associated infection was defined as infection occurring within 7 days after admission. Poor outcome (modified Rankin score >2) was recorded at discharge and at 1 year. Results: Stroke-associated infection occurred in 78 patients (15%); 39 of these (7.5%) had pneumonia and 23 (4.4%) had urinary tract infection. Overall, 276 patients (53%) had a poor outcome at 1 year. Poor outcome was recorded in 69 patients with stroke-associated infection (88%), and 37 of the 78 patients with stroke-associated infection (47%) had died at 1 year. After adjustment for confounders, stroke-associated infection was associated with poor outcome at discharge [odds ratio (OR) 2.6, 95% confidence interval (CI) 1.0–6.7] and at 1 year (OR 3.8, 95% CI 1.8–8.9). Pneumonia had a stronger association with poor outcome at 1 year (OR 10, 95% CI 2.2–46). Conclusions: This study suggests that stroke-associated infection, in particular pneumonia, is independently associated with poor functional outcome after ischemic stroke.

Keywords:
Acute ischemic stroke, Infection, Pneumonia, Urinary tract infection, Poor outcome, Mortality
1.
Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR: Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004;11:49–53.
2.
Azzimondi G, Bassein L, Nonino F, et al: Fever in acute stroke worsens prognosis. A prospective study. Stroke 1995;26:2040–2043.
3.
Davalos A, Cendra E, Teruel J, Martinez M, Genis D: Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990;40:1865–1869.
4.
Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al: Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004;164:1761–1768.
5.
Jorgensen HS, Reith J, Nakayama H, Kammersgaard LP, Raaschou HO, Olsen TS: What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study. Stroke 1999;30:2008–2012.
6.
Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003;60:620–625.
7.
Kwan J, Hand P: Infection after acute stroke is associated with poor short-term outcome. Acta Neurol Scand 2007;115:331–338.
8.
Spratt N, Wang Y, Levi C, Ng K, Evans M, Fisher J: A prospective study of predictors of prolonged hospital stay and disability after stroke. J Clin Neurosci 2003;10:665–669.
9.
Vargas M, Horcajada JP, Obach V, et al: Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 2006;37:461–465.
10.
Walter U, Knoblich R, Steinhagen V, Donat M, Benecke R, Kloth A: Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 2007;254:1323–1329.
11.
Weimar C, Ziegler A, Konig IR, Diener HC: Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002;249:888–895.
12.
Chamorro A, Horcajada JP, Obach V, et al: The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 2005;36:1495–1500.
13.
Fassbender K, Dempfle CE, Mielke O, et al: Proinflammatory cytokines: indicators of infection in high-risk patients. J Lab Clin Med 1997;130:535–539.
14.
Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K: Aetiology of fever in patients with acute stroke. J Intern Med 1999;246:203–209.
15.
Ovbiagele B, Hills NK, Saver JL, Johnston SC: Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis 2006;15:209–213.
16.
Pittock SJ, Meldrum D, Hardiman O, Thornton J, Brennan P, Moroney JT: The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis 2003;12:1–7.
17.
Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S: Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 2001;32:523–529.
18.
Wong AA, Davis JP, Schluter PJ, Henderson RD, O’Sullivan JD, Read SJ: The time course and determinants of temperature within the first 48 h after ischaemic stroke. Cerebrovasc Dis 2007;24:104–110.
19.
Ersoz M, Ulusoy H, Oktar MA, Akyuz M: Urinary tract infection and bacteriurua in stroke patients: frequencies, pathogen microorganisms, and risk factors. Am J Phys Med Rehabil 2007;86:734–741.
20.
Davenport RJ, Dennis MS, Wellwood I, Warlow CP: Complications after acute stroke. Stroke 1996;27:415–420.
21.
Grau AJ, Buggle F, Schnitzler P, Spiel M, Lichy C, Hacke W: Fever and infection early after ischemic stroke. J Neurol Sci 1999;171:115–120.
22.
Hilker R, Poetter C, Findeisen N, et al: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003;34:975–981.
23.
Johnston KC, Li JY, Lyden PD, et al: Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998;29:447–453.
24.
Langhorne P, Stott DJ, Robertson L, et al: Medical complications after stroke: a multicenter study. Stroke 2000;31:1223–1229.
25.
Sellars C, Bowie L, Bagg J, et al: Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007;38:2284–2291.
26.
van der Worp HB, Kappelle LJ: Complications of acute ischaemic stroke. Cerebrovasc Dis 1998;8:124–132.
27.
Weimar C, Roth MP, Zillessen G, et al: Complications following acute ischemic stroke. Eur Neurol 2002;48:133–140.
28.
Dziewas R, Ritter M, Schilling M, et al: Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004;75:852–856.
29.
Silver FL, Norris JW, Lewis AJ, Hachinski VC: Early mortality following stroke: a prospective review. Stroke 1984;15:492–496.
30.
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457–507.
31.
Harms H, Prass K, Meisel C, et al: Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS ONE 2008;3:e2158.
32.
Schwarz S, Al-Shajlawi F, Sick C, Meairs S, Hennerici MG: Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). Stroke 2008;39:1220–1227.
33.
Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J 1965;14:61–65.
34.
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
35.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van GJ: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
36.
Wade DT, Collin C: The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 1988;10:64–67.
37.
Kwan J, Roberts HC, Englyst N: Do we really understand the pathophysiology and clinical impact of poststroke infection? Stroke 2006;37:1656.
38.
Carnaby G, Hankey GJ, Pizzi J: Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol 2006;5:31–37.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.